Ranitidine Bismuth Citrate

Generic Name: ranitidine bismuth citrate

Over-the-Counter (OTC)

Manufactured by GLAXOSMITHKLINE. Dosage form: TABLET. Route: ORAL. Active ingredients: RANITIDINE BISMUTH CITRATE (400MG). Application: NDA020559.

Overview

Manufactured by GLAXOSMITHKLINE. Dosage form: TABLET. Route: ORAL. Active ingredients: RANITIDINE BISMUTH CITRATE (400MG). Application: NDA020559.

Dosage

Available as tablet for oral use.

Related Medications

Bevacizumab-bvzr

bevacizumab-bvzr

Vascular Endothelial Growth Factor Inhibitor [EPC]

11 DESCRIPTION Bevacizumab-bvzr is a vascular endothelial growth factor inhibitor. Bevacizumab-bvzr is a recombinant humanized monoclonal IgG1 antibody that contains human framework regions and murine complementarity-determining regions. Bevacizumab-bvzr has an approximate molecular weight of 149 kDa. Bevacizumab-bvzr is produced in a mammalian cell (Chinese Hamster Ovary) expression system.

Valeriana Officinalis, Hydrocotyle Asiatica, Melatonin, Cerebrum Suis, Hypothalamus Suis, Pineal Gland (suis), Scutellaria Lateriflora, Stellaria Media, Calcarea Carbonica, Zincum Metallicum, Aurum Metallicum, Dopamine (hydrochloride), Serotonin (hydrochloride), Magnesia Muriatica

valeriana officinalis, hydrocotyle asiatica, melatonin, cerebrum suis, hypothalamus suis, pineal gland (suis), scutellaria lateriflora, stellaria media, calcarea carbonica, zincum metallicum, aurum metallicum, dopamine (hydrochloride), serotonin (hydrochloride), magnesia muriatica

Standardized Chemical Allergen [EPC]

PURPOSE: Provides potentized homeo-nutritional support of the pineal.† †Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

Nedosiran

nedosiran

11 DESCRIPTION RIVFLOZA injection contains nedosiran, a double-stranded small interfering RNA (siRNA) with four covalently attached N -acetyl-D-galactosamine (GalNAc) residues. Nedosiran targets lactate dehydrogenase A (LDHA) in hepatocytes via GalNAc-mediated delivery. The structural formula of the nedosiran sodium drug substance is presented below: The molecular formula of nedosiran sodium is C 662 H 808 F 19 N 231 O 413 P 57 S 6 Na 57 with a molecular weight of 22,238 Da.

Medical Disclaimer

This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.